201 related articles for article (PubMed ID: 29277958)
21. CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study.
Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
Eur J Gynaecol Oncol; 1998; 19(1):46-9. PubMed ID: 9476059
[TBL] [Abstract][Full Text] [Related]
22. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.
Azar KK; Tani M; Yasuda H; Sakai A; Inoue M; Sasagawa T
Hum Pathol; 2004 Nov; 35(11):1376-84. PubMed ID: 15668895
[TBL] [Abstract][Full Text] [Related]
23. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
24. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.
Lee S; Kim JH; Kim H; Kang JW; Kim SH; Yang Y; Kim J; Park J; Park S; Hong J; Yoon DY
Immunology; 2011 Mar; 132(3):410-20. PubMed ID: 21208204
[TBL] [Abstract][Full Text] [Related]
25. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Oct; 59(10):1044-51. PubMed ID: 16537673
[TBL] [Abstract][Full Text] [Related]
26. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Int J Cancer; 2015 Jan; 136(2):350-9. PubMed ID: 24842156
[TBL] [Abstract][Full Text] [Related]
27. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
28. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
29. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
[TBL] [Abstract][Full Text] [Related]
31. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
[TBL] [Abstract][Full Text] [Related]
32. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
Pacchiarotti A; Ferrari F; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
Int J Cancer; 2014 Feb; 134(4):897-904. PubMed ID: 23913416
[TBL] [Abstract][Full Text] [Related]
34. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
35. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3).
González-Bosquet E; Esteva C; Muñoz-Almagro C; Ferrer P; Pérez M; Lailla JM
Gynecol Oncol; 2008 Oct; 111(1):9-12. PubMed ID: 18684497
[TBL] [Abstract][Full Text] [Related]
36. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
Harbhajanka A; Dahoud W; Michael CW
Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
[TBL] [Abstract][Full Text] [Related]
37. Cervical squamous intraepithelial lesions and associated cervical infections in an HIV-positive population in Rural Mpumalanga, South Africa.
Swanepoel PJ; Michelow P; Du Plessis R; Proudfoot IG; Tarr GA; Bockel SL; Swanepoel CJ
Cytopathology; 2013 Aug; 24(4):264-71. PubMed ID: 22817687
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of IL-2 and IL-23 in Cervical Biopsies of Cervical Intraepithelial Lesions: A Cross-Sectional Study.
Petrini CG; Bastos LB; Duarte G; Dos Santos Melli PP; Alves-Filho JC; Quintana SM
Acta Cytol; 2020; 64(5):442-451. PubMed ID: 32599588
[TBL] [Abstract][Full Text] [Related]
39. Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA⁺ and DNA⁻ cervical lesions.
Ali KS; Ali HY; Jubrael JM
J Immunotoxicol; 2012; 9(2):168-72. PubMed ID: 22471745
[TBL] [Abstract][Full Text] [Related]
40. CD4
Brito MJ; Sequeira P; Silva I; Quintas A; Martins C; Félix A
Int J Infect Dis; 2021 Feb; 103():370-377. PubMed ID: 33157285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
